Katherine Lynn Muhlstadt, PHARMD | |
3701 Loop Rd, Tuscaloosa, AL 35404-5015 | |
(205) 554-2000 | |
Not Available |
Full Name | Katherine Lynn Muhlstadt |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 3701 Loop Rd, Tuscaloosa, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033421433 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 051.294186 (Illinois) | Primary |
Mailing Address | Practice Location Address |
---|---|
Katherine Lynn Muhlstadt, PHARMD 3701 Loop Rd, Tuscaloosa, AL 35404-5015 Ph: (205) 554-2000 | Katherine Lynn Muhlstadt, PHARMD 3701 Loop Rd, Tuscaloosa, AL 35404-5015 Ph: (205) 554-2000 |
News Archive
According to a new landmark study published in The New England Journal of Medicine, infusions of clotting factor VIII used preventively can significantly reduce the risk of developing joint damage associated with joint bleeding in young children with hemophilia A.
As Mayor Michael Bloomberg's term comes to a close, the latest research conducted by Columbia University's Mailman School of Public indicates that he leaves a legacy of ambitious public health policies from pioneering restrictions on trans fats and smoking to investments in green spaces and bicycle lanes that have improved the health and increased the life expectancy of New Yorkers. The paper takes a behind-the-scenes look at the Bloomberg Administration to evaluate the evidence and build public support for improving health in the city-which also can serve as a blueprint for health policy in cities across the country.
BRCA gene mutation has been associated with cancers such as breast cancer. The BRCA gene mutation detection had resulted in a prophylactic double mastectomy for actress Angelina Jolie anticipating cancer. Now a new study has shown that having a BRCA gene mutation and being diagnosed with breast cancer does not raise the risk of death after diagnosis. The study was published in the latest issue of the journal The Lancet Oncology.
New technologies and methods are spurring a renaissance in the study of organogenesis. Organogenesis, essentially the process through which a group of cells becomes a functioning organ, has important connections to biological processes at the cellular and developmental levels, and its study offers great potential for medical treatments through tissue engineering approaches.
Phenex Pharmaceuticals AG announced today the start of a first-in-man Phase I study with its clinical drug candidate Px-102, a synthetic non-steroidal FXR agonist. The volunteers of the first dose level received the drug and showed no signs of discomfort or other adverse effects.
› Verified 1 days ago
Vito J Carruba, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3325 University Blvd E, Tuscaloosa, AL 35404 Phone: 205-556-3800 Fax: 205-556-0142 | |
Brittany Nicole Barnes, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3701 Loop Rd, Tuscaloosa, AL 35404 Phone: 205-554-2000 | |
Dr. Shelia Renee Miller, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4201 University Blvd E, Tuscaloosa, AL 35404 Phone: 205-553-9647 | |
Mr. Mike Pritchett, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4400 University Blvd E, Tuscaloosa, AL 35404 Phone: 205-553-6188 Fax: 205-553-6348 | |
Samantha Beams I, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3611 Rice Mine Rd Ne Lot 140, Tuscaloosa, AL 35406 Phone: 205-393-5876 | |
Mr. Jamie Floyd Sullivan, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3701 Loop Rd, Tuscaloosa, AL 35404 Phone: 205-554-2000 | |
Mr. Robert Shane Ballard, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4201 University Blvd E, Tuscaloosa, AL 35404 Phone: 205-553-9477 Fax: 205-553-9773 |